Development of a new synthetic route of the key intermediate of riociguat

References

• Stasch, J. P.; Pacher, P.; Evgenov, O. V. Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease. Circulation 2011, 123, 2263–2273. DOI: 10.1161/CIRCULATIONAHA.110.981738.
   PubMed Web of Science ®Google Scholar
• Machado, R. F.; Nerkar, M.; Dweik, R. A.; Hammel, J.; Janocha, A.; Pyle, J.; Laskowski, D.; Jennings, C.; Arroliga, A.; Erzurum, S. C. Nitric Oxide and Pulmonary Arterial Pressures in Pulmonary Hypertension. Free Radic. Biol. Med. 2004, 37, 1010–1017. DOI: 10.1016/j.freeradbiomed.2004.06.039.
   PubMed Web of Science ®Google Scholar
• Mittendorf, J.; Weigand, S.; Alonso-Alija, C.; Bischoff, E.; Feurer, A.; Gerisch, M.; Kern, A.; Knorr, A.; Lang, D.; Muenter, K.; et al. Discovery of Riociguat (Bay 63−2521): a Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension. ChemMedChem 2009, 4, 853–865. DOI: 10.1021/acs.jmedchem.7b00449.
   PubMed Web of Science ®Google Scholar
• Arava, V.; Gogireddy, S. R. An Expeditious Synthesis of Riociguat, a Pulmonary Hypertension Drug. Der Pharma Chemica 2013, 5, 232–239. DOI: 10.1080/00021369.1985.10866911.
   Google Scholar
• Schirok, H.; Griebenow, N.; Fürstner, C.; Dilmac, A. M. Use of 3-(Trifluoromethyl)-1H-Pyrazolo-[3,4-b]Pyridine as a Versatile Building Block. Tetrahedron 2015, 71, 5597–5601. DOI: 10.1016/j.tet.2015.06.050.
   Web of Science ®Google Scholar
• Teixeira, F. C.; Lucas, C.; Curto, M. J. M.; Neves, M.; Duarte, mt.; André, V.; Teixeira, A. P. S. New 1-Hydroxy-1,1-Bisphosphonates Derived from 1H-Pyrazolo[3,4-b]Pyridine:synthesis and Characterization. J. Brazil Chem. Soc. 2013, 24, 1295–1306. DOI: 10.5935/0103-5053.20130164.
   Web of Science ®Google Scholar
• Huang, S.; Lin, R.; Yu, Y.; Lu, Y.; Connolly, P. J.; Chiu, J.; Li, S.; Emanuel, S. L.; Middleton, S. A. Synthesis of 3-(1H-Benzimidazol-2-yl)-5-Isoquinolin-4-Ylpyrazolo[1,2-b]-Pyridine, a Potent Cyclin Dependent Kinase 1 (CDK1) Inhibitor. Bioorg. Med. Chem. Lett. 2007, 17, 1243–1245. DOI: 10.1016/j.bmcl.2006.12.031.
   PubMed Web of Science ®Google Scholar
• Chang, Y.; Lu, X.; Shibu, M.; Dai, A.; Luo, Y.; Zhang, J.; Li, Y.; Zhao, Y.; Zhang, P.; Xu, Z.; et al. Structure Based Design of N‑(3-((1H‑Pyrazolo[3,4‑b]Pyridin-5-yl)Ethynyl)Benzenesulfonamides as Selective Leucine-Zipper and Sterile‑α Motif Kinase (ZAK) Inhibitors. J. Med. Chem. 2017, 60, 5927–5932. DOI: 10.1021/acs.jmedchem.7b00572.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Cheng, H.; Zhang, Z.; Zhuang, X.; Luo, J.; Long, H.; Zhou, Y.; Xu, Y.; Taghipouran, R.; Li, D.; et al. N‑(3-Ethynyl-2,4-Difluorophenyl)Sulfonamide Derivatives as Selective Raf Inhibitors. ACS Med. Chem. Lett. 2015, 6, 543–547. DOI: 10.1021/acsmedchemlett.5b00039.
   PubMed Web of Science ®Google Scholar
• Alho, M. M.; García-Sánchez, R. N.; Nogal-Ruiz, J. J.; Escario, J. A.; Gómez-Barrio, A.; Martínez-Fernández, A. R.; Arán, V. J. Synthesis and Evaluation of 1,1'-Hydrocarbylenebis(Indazol-3-Ols) as Potential Antimalarial Drugs. ChemMedChem 2009, 4, 78–87. DOI: 10.1002/cmdc.200800176.
   PubMed Web of Science ®Google Scholar
• Masuda, N.; Yamamoto, O.; Fujii, M.; Ohgami, T.; Moritomo, A.; Kontani, T.; Kageyama, T.; Ohta, M. Regioselective Alkylation of Thiazolylsulfonamides: direct and Efficient Synthesis of 3-Alkylthiazolidene Derivatives. Synthetic Commun. 2005, 35, 2305–2316. DOI: 10.1080/00397910500186730.
   Web of Science ®Google Scholar
• The CCDC deposition number is 2226837. www.ccdc.cam.ac.uk/structures
   Google Scholar
• The CCDC deposition number is 2227372. www.ccdc.cam.ac.uk/structures
   Google Scholar
• Gordon, D. W. An Improved Synthesis of YC-1. Synlett, 1998, 1998, 1065–1066. DOI: 10.1055/s-1998-1882.
   Google Scholar
• Mérour, J. Y.; Cossais, F. Regioselective N-Alkylation of Methyl Indole-2-Carboxylate. Synthetic Commun. 1993, 23, 1813–1820. DOI: 10.1080/00397919308011281.
   Web of Science ®Google Scholar
• Follmann, M.; Ackerstaff, J.; Redlich, G.; Wunder, F.; Lang, D.; Kern, A.; Fey, P.; Griebenow, N.; Kroh, W.; Becker, E. W.; et al. Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (Bay 1021189) for the Treatment of Chronic Heart Failure. J. Med. Chem. 2017, 60, 5146–5161. DOI: 10.1021/acs.jmedchem.7b00449.
   PubMed Web of Science ®Google Scholar
• Cai, L.; Liu, X.; Tao, X.; Shen, D. Efficient Microwave-Assisted Cyanation of Aryl Bromide. Synthetic Commun. 2004, 34, 1215–1221. DOI: 10.1081/SCC-120030308.
   Web of Science ®Google Scholar
• Dehmlow, E. V.; Balschukat, D. Azulene Durch Vakuumpyrolyse Von Halogentricyclo[7.1.0.04.6]Decadienen. Chem. Ber. 1985, 118, 3805–3816. DOI: 10.1002/chin.198551149.
   Google Scholar
• Cohen, D. T.; Buchwald, S. L. Mild Palladium-Catalyzed Cyanation of (Hetero)Aryl Halides and Triflates in Aqueous Media. Org. Lett. 2015, 17, 202–205. DOI: 10.1021/ol5032359.
   PubMedGoogle Scholar
• Senecal, T. D.; Shu, W.; Buchwald, S. L. A General, Practical Palladium-Catalyzed Cyanation of (Hetero)Aryl Chlorides and Bromides. Angew. Chem. Int. Ed. Engl. 2013, 52, 10035–10039. DOI: 10.1002/anie.201304188.
   PubMed Web of Science ®Google Scholar
• Kolasa, T.; Brioni, J. D.; Gracias, V.; Nakane, M.; Patel, mv.; Rohde, J. Indazole Derivatives That are Activators of Soluble Guanylate Cyclase. PCT International Patent Application WO 03076408A2, Sep 18, 2003.
   Google Scholar